Table 1. Subject demographics (safety population) Reference Overall CT-P6 group trastuzumab Characteristic (N = 70) (N = 35) group (N = 35) Age (years) Median 34.5 37.0 32.0 18–55 20–55 18–54 Range Sex, n (%) 70 (100.0) 35 (100.0) 35 (100.0) Male Height (cm) 175.2 (7.8) 175.7 (8.2) 174.8 (7.4) Mean (SD) Range 159.6–192.6 159.6–192.6 160.3–191.8 Weight (kg) Mean (SD) 77.3 (9.9) 77.8 (8.6) 76.8 (11.2) 59.2–101.8 62.8–95.2 59.2–101.8 Range Body mass index (kg/m2) 25.2 (2.8) 25.3 (2.7) 25.1 (3.0) Mean (SD) Range 19.4–29.8 19.8–29.7 19.4–29.8 Ethnicity, n (%) Japanese 24 (34.3) 12 (34.3) 12 (34.3) 34 (48.6) 19 (54.3) 15 (42.9) White Black or African American 12 (17.1) 4 (11.4) 8 (22.9) Abbreviation: SD = standard deviation
Table 1. Subject demographics (safety population) Characteristic Overall (N = 70) CT-P6 group (N = 35) Reference trastuzumab group (N = 35) Age (years) Median Range 34.5 18–55 37.0 20–55 32.0 18–54 Sex, n (%) Male 70 (100.0) 35 (100.0) 35 (100.0) Height (cm) Mean (SD) Range 175.2 (7.8) 159.6–192.6 175.7 (8.2) 159.6–192.6 174.8 (7.4) 160.3–191.8 Weight (kg) Mean (SD) Range 77.3 (9.9) 59.2–101.8 77.8 (8.6) 62.8–95.2 76.8 (11.2) 59.2–101.8 Body mass index (kg/m2) Mean (SD) Range 25.2 (2.8) 19.4–29.8 25.3 (2.7) 19.8–29.7 25.1 (3.0) 19.4–29.8 Ethnicity, n (%) Japanese White Black or African American 24 (34.3) 34 (48.6) 12 (17.1) 12 (34.3) 19 (54.3) 4 (11.4) 12 (34.3) 15 (42.9) 8 (22.9) Abbreviation: SD = standard deviation